Award
Delivery Order #SPE2DR26F7WJ4
AmerisourceBergen Delivery Order for Xeljanz XR Tablets
Buyer
Defense Logistics Agency
Award Amount
$13,896.79
Ceiling
$13,896.79
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26F7WJ4
NAICS
424210
This award is a delivery order contract issued under an existing indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corp, a leading pharmaceutical products distributor. The contract involves procuring a specified quantity of Xeljanz XR 11 MG tablets, a medication used in the treatment of certain autoimmune conditions. The delivery order supports ongoing healthcare operations by ensuring timely access to essential pharmaceutical products. The short-term scope covers the supply and delivery of these tablets within a defined multi-day period, reflecting a targeted, urgent procurement. This award follows competitive IDV procedures, leveraging an established contract to efficiently acquire the medication. The delivery is set to occur within a concise timeframe, ensuring prompt fulfillment to meet healthcare needs. The parent IDV facilitates ongoing pharmaceutical supply contracts, highlighting AmerisourceBergen's critical role in supporting public health initiatives.
Description
4571063597!XELJANZ XR 11 MG TABLET UU 30S